Therapeutic Potential of Small Activating RNAs (saRNAs) in Human Cancers

Author(s): Sorah Yoon*, John J. Rossi*.

Journal Name: Current Pharmaceutical Biotechnology

Volume 19 , Issue 8 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: RNA is increasingly recognized as a powerful molecule that can be used to control gene expression. Sophisticated, well-engineered RNA-based regulators are being developed as oligotherapeutics.

Methods: In particular, small activating RNAs (saRNAs) are promising therapeutic options for targeting human diseases. Numerous saRNAs targeting multiple cancers have been developed in preclinical models. One saRNA targeting C/EBPα is currently undergoing clinical trials in liver cancer.

Results and Conclusion: In this review, we describe the current working model of the intracellular mechanism of saRNA, discuss the recent progress of saRNA therapeutics in preclinical and clinical trials, and current advances in targeted delivery using aptamers in detail.

Keywords: saRNAs, therapeutics, human cancers, intracellular mechanism, targeted delivery, aptamers, clinic.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 19
ISSUE: 8
Year: 2018
Page: [604 - 610]
Pages: 7
DOI: 10.2174/1389201019666180528084059

Article Metrics

PDF: 34
HTML: 2